FDA Approved: ZORTRESS — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for ZORTRESS (everolimus) submitted by Novartis Pharmaceuticals Corporation. The action likely adds or modifies a la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma
• Tuberous Sclerosis Complex-associated Renal Angiomyolipoma
• Tuberous Sclerosis Complex-associated Subependymal Giant Cell Astrocytoma

Drugs mentioned

• Zortress (everolimus)

Snippet

SUPPL AP for ZORTRESS (EVEROLIMUS)